1. Home
  2. AKRO vs ALGM Comparison

AKRO vs ALGM Comparison

Compare AKRO & ALGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKRO
  • ALGM
  • Stock Information
  • Founded
  • AKRO 2017
  • ALGM 1990
  • Country
  • AKRO United States
  • ALGM United States
  • Employees
  • AKRO N/A
  • ALGM N/A
  • Industry
  • AKRO Biotechnology: Pharmaceutical Preparations
  • ALGM Semiconductors
  • Sector
  • AKRO Health Care
  • ALGM Technology
  • Exchange
  • AKRO Nasdaq
  • ALGM Nasdaq
  • Market Cap
  • AKRO 4.5B
  • ALGM 4.6B
  • IPO Year
  • AKRO 2019
  • ALGM 2020
  • Fundamental
  • Price
  • AKRO $54.34
  • ALGM $23.34
  • Analyst Decision
  • AKRO Buy
  • ALGM Strong Buy
  • Analyst Count
  • AKRO 10
  • ALGM 10
  • Target Price
  • AKRO $73.56
  • ALGM $37.40
  • AVG Volume (30 Days)
  • AKRO 1.7M
  • ALGM 2.6M
  • Earning Date
  • AKRO 11-07-2025
  • ALGM 10-30-2025
  • Dividend Yield
  • AKRO N/A
  • ALGM N/A
  • EPS Growth
  • AKRO N/A
  • ALGM N/A
  • EPS
  • AKRO N/A
  • ALGM N/A
  • Revenue
  • AKRO N/A
  • ALGM $788,395,000.00
  • Revenue This Year
  • AKRO N/A
  • ALGM $22.84
  • Revenue Next Year
  • AKRO N/A
  • ALGM $14.98
  • P/E Ratio
  • AKRO N/A
  • ALGM N/A
  • Revenue Growth
  • AKRO N/A
  • ALGM N/A
  • 52 Week Low
  • AKRO $21.34
  • ALGM $16.38
  • 52 Week High
  • AKRO $58.40
  • ALGM $38.45
  • Technical
  • Relative Strength Index (RSI)
  • AKRO 68.92
  • ALGM 22.37
  • Support Level
  • AKRO $54.10
  • ALGM $26.09
  • Resistance Level
  • AKRO $54.37
  • ALGM $27.89
  • Average True Range (ATR)
  • AKRO 0.18
  • ALGM 1.53
  • MACD
  • AKRO -0.22
  • ALGM -0.54
  • Stochastic Oscillator
  • AKRO 89.00
  • ALGM 3.22

About AKRO Akero Therapeutics Inc.

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.

About ALGM Allegro MicroSystems Inc.

Allegro Microsystems Inc is a designer, developer, fabless manufacturer, and marketer of sensor ICs and application-specific analog power ICs for automotive and industrial markets. Its Sensor IC allows customers to precisely measure motion, speed, position, and current, and Power ICs include high-temperature and high-voltage capable motor drivers, power management, and LED driver ICs. Its products are divided into three categories such as SENSE which includes Current Sensors, Switches and Latches, and Interface ICs among others; REGULATE which includes Regulators, ClearPower Modules, and LED Drivers; and DRIVE which includes BLDC Drivers, Brush DC, and others. Key revenue for the company is generated from Greater China and the rest from the United States, Japan, Europe, and other regions.

Share on Social Networks: